Amenichi Consulting
Amenichi Consulting, LLC is a premier global resource specializing in Japan-US life science consulting. They focus on regulatory affairs, compliance, business development, and market strategy, bridging the gap between Japan and the US. Their team of bilingual experts provides tailored solutions to help life science companies navigate market entry, regulatory requirements, and strategic growth in both countries.
Industries
Nr. of Employees
small (1-50)
Products
U.S.-Japan Life Sciences Consulting Services
Expert advisory and consulting services connecting US and Japan life sciences firms, simplifying market expansion, and building strategic partnerships.
U.S.-Japan Life Sciences Consulting Services
Expert advisory and consulting services connecting US and Japan life sciences firms, simplifying market expansion, and building strategic partnerships.
Services
Consulting for regulatory strategy, submissions, QMS alignment, audits, validation, and remediation for US and Japanese markets.
Market entry planning, competitive analysis, product launch planning, contract sales, distributor partnerships, and account management for US/Japan engagements.
Vendor selection strategy, contract analysis, supply chain management, and support for initial importer/US agent arrangements.
Design and implementation of compliance programs, compliance risk assessments, and regulatory and commercial due diligence for M&A.
KOL engagement and medical/scientific liaison activities to support commercialization, evidence generation, and payer engagement.
Consulting for regulatory strategy, submissions, QMS alignment, audits, validation, and remediation for US and Japanese markets.
Market entry planning, competitive analysis, product launch planning, contract sales, distributor partnerships, and account management for US/Japan engagements.
Vendor selection strategy, contract analysis, supply chain management, and support for initial importer/US agent arrangements.
Design and implementation of compliance programs, compliance risk assessments, and regulatory and commercial due diligence for M&A.
KOL engagement and medical/scientific liaison activities to support commercialization, evidence generation, and payer engagement.
Expertise Areas
- Regulatory compliance for US and Japan
- Quality management systems (QMS) and validation
- Market entry and commercialization strategy (US/Japan)
- Supply chain and vendor selection
Key Technologies
- Regulatory submission pathways (e.g., Pre-Submission, 510(k), De Novo)
- Quality management systems (QMS) frameworks
- Clinical software validation methodologies
- GMP readiness and inspection processes